BiotechTube

IVT aflibercept + Sham SC + SC CLS-TA

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Diabetic Macular Edema

Conditions

Diabetic Macular Edema

Trial Timeline

Jul 11, 2017 → Apr 17, 2018

NCT ID
NCT03126786

About IVT aflibercept + Sham SC + SC CLS-TA

IVT aflibercept + Sham SC + SC CLS-TA is a phase 2 stage product being developed by Clearside Biomedical for Diabetic Macular Edema. The current trial status is completed. This product is registered under clinical trial identifier NCT03126786. Target conditions include Diabetic Macular Edema.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT03126786Phase 2Completed

Competing Products

20 competing products in Diabetic Macular Edema

See all competitors
ProductCompanyStageHype Score
CHF6467 activeComac MedicalPhase 1/2
33
Ruboxistaurin mesylateEli LillyPhase 3
77
KVD001 InjectionKalVista PharmaceuticalsPhase 2
47
KVD001 InjectionKalVista PharmaceuticalsPhase 1
28
Baricitinib + PlaceboEli LillyPhase 2
52
LY3857210 + PlaceboEli LillyPhase 2
52
UBX1325Unity BiotechnologyPhase 2
44
Aflibercept + foselutoclaxUnity BiotechnologyPhase 2
44
UBX1325Unity BiotechnologyPhase 1
25
CT-P42 + EyleaCelltrionPhase 3
77
Pregabalin 150mg + Alpha-lipoic acid 480mg + Pregabalin 150mg + Alpha-Lipoic Acid 480mgYuhanApproved
85
Anplag(Sarpogrelate) + PlaceboYuhanApproved
85
CS-3150 + placeboDaiichi SankyoPhase 2
52
DS-5565 tablet + pregabalin capsule + Placebo tablet + placebo capsuleDaiichi SankyoPhase 2
52
olmesartan medoxomil + Placebo TabletsDaiichi SankyoPhase 3
77
DS-5565 + placeboDaiichi SankyoPhase 3
77
Mirogabalin + PlaceboDaiichi SankyoPhase 3
77
DS-5565Daiichi SankyoPhase 3
77
Beraprost sodiumAstellas PharmaPre-clinical
23
ASP8825 + PlaceboAstellas PharmaPhase 2
52

Other Products from Clearside Biomedical

4 mg CLS-TA Suprachoriodal InjectionPhase 3
69
suprachoroidal CLS-TA + suprachoroidal sham + Lucentis or AvastinPhase 3
69
4mg CLS-TA Suprachoriodal Injection + Sham ProcedurePhase 3
69
suprachoroidal CLS-TA + suprachoroidal sham + IVT afliberceptPhase 3
69
4 mg CLS-TA + Sham + IVT afliberceptPhase 2
44